These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
143 related items for PubMed ID: 19142809
1. Impact of HLA on the underlying primary diseases in Turkish patients with end-stage renal disease. Karahan GE, Seyhun Y, Oguz FS, Kekik C, Onal AE, Yazici H, Turkmen A, Aydin AE, Sever MS, Eldegez U, Carin MN. Ren Fail; 2009; 31(1):44-9. PubMed ID: 19142809 [Abstract] [Full Text] [Related]
6. Human leucocyte antigens: their association with end-stage renal disease in Saudi patients awaiting transplantation. Almogren A, Shakoor Z, Hamam KD. Br J Biomed Sci; 2012; 69(4):159-63. PubMed ID: 23304791 [Abstract] [Full Text] [Related]
10. Geographic, ethnic, age-related and temporal variation in the incidence of end-stage renal disease in Europe, Canada and the Asia-Pacific region, 1998-2002. ESRD Incidence Study GroupDepartment of Preventive and Social Medicine, University of Otago, PO Box 913, Dunedin, New Zealand. margaret.mccredie@stonebow.otago.ac.nz, Stewart JH, McCredie MR, Williams SM. Nephrol Dial Transplant; 2006 Aug; 21(8):2178-83. PubMed ID: 16595584 [Abstract] [Full Text] [Related]
11. Association of HLA class I and class II alleles with psoriasis vulgaris in Turkish population. Influence of type I and II psoriasis. Atasoy M, Pirim I, Bayrak OF, Ozdemir S, Ikbal M, Erdem T, Aktas A. Saudi Med J; 2006 Mar; 27(3):373-6. PubMed ID: 16532100 [Abstract] [Full Text] [Related]
12. Alport syndrome: HLA association and kidney graft outcome. Barocci S, Fiordoro S, Santori G, Valente U, Mossa M, Antonelli P, Ferrara GB, Cannella G, Nocera A. Eur J Immunogenet; 2004 Jun; 31(3):115-9. PubMed ID: 15182324 [Abstract] [Full Text] [Related]
15. The changing spectrum of primary glomerular diseases within 15 years: a survey of 3331 patients in a single Chinese centre. Zhou FD, Zhao MH, Zou WZ, Liu G, Wang H. Nephrol Dial Transplant; 2009 Mar; 24(3):870-6. PubMed ID: 18940885 [Abstract] [Full Text] [Related]
16. HLA class I and class II genotyping in patients with chronic urticaria. Coban M, Erdem T, Ozdemir S, Pirim I, Atasoy M, Ikbal M. Int Arch Allergy Immunol; 2008 Mar; 147(2):135-9. PubMed ID: 18520158 [Abstract] [Full Text] [Related]
17. A lifetime versus a graft life approach redefines the importance of HLA matching in kidney transplant patients. Meier-Kriesche HU, Scornik JC, Susskind B, Rehman S, Schold JD. Transplantation; 2009 Jul 15; 88(1):23-9. PubMed ID: 19584676 [Abstract] [Full Text] [Related]